{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:00:34Z","timestamp":1768388434157,"version":"3.49.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Highlighting arterial stiffness in Community Pharmacies (CPh) has been met with considerable interest in Portugal, Austria, and Spain. TOGETHER aims to evaluate whether empowering hypertensive subjects by determining blood pressure (BP) and vascular aging in CPh increases hypertension (HTN) control, while establishing paths of lasting cooperation between General Practitioners (GP) and CPh.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>TOGETHER is a cluster-randomized, prospective study in Portugal, Austria, and Spain. All consecutive subjects entering CPh will be offered BP measurement and ambulatory BP monitoring (ABPM) for those with BP\u202f\u2265\u202f140\/90\u202fmmHg. CPh will be randomly assigned to a usual care arm (including health education for HTN). In the experimental care group, vascular aging (VA) will be additionally assessed by estimating aortic pulse wave velocity using brachial oscillometry. In this group, health education will include VA, which will also be communicated to GPs. In both groups, HTN will be treated by GPs according to usual clinical practice. A second evaluation with ABPM will be performed after 6\u202fmonths, and the percentage of patients with controlled hypertension will be compared between both arms. The degree of CPh\/GP interaction and patients\u00b4 adherence will be assessed through validated surveys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Five fundamental unmet needs will be addressed by TOGETHER: 1) the lack of HTN screening programs; 2) implementation of the simpler and more informative VA concept (\u201cYour arteries are 10\u202fyears older than you\u201d); 3) understanding CV risk on an individual basis (individual VA) should improve patient adherence and reduce physician inertia; 4) implementation of health educational programs, combined with the concept of VA; 5) higher collaboration and development of a team-based approach to HTN care between CPh and GP. The complementary organizational settings and strengths of CPh and GP will allow TOGETHER to create new strategies for the early identification and intervention in uncontrolled HTN, encompassing both lifestyle and medical treatment, while considering social, economic, and behavioral aspects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/<\/jats:ext-link>\n                      , identifier FP-1533-ROD-SAL-2024-01.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1723100","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:41:35Z","timestamp":1768372895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular age as a key for a team-based approach to manage blood pressure bridging community pharmacists and primary healthcare physicians\u2014The TOGETHER trial"],"prefix":"10.3389","volume":"13","author":[{"given":"Enrique","family":"Rodilla","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hypertension and Vascular Risk Unit, Hospital de Sagunto","place":["Valencia, Spain"]},{"name":"Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO)","place":["Valencia, Spain"]},{"name":"Department of Medicine and Surgery, Universidad Cardenal Herrera-CEU, CEU Universities","place":["Valencia, Spain"]}]},{"given":"Monika","family":"Aichberger","sequence":"additional","affiliation":[{"name":"Austrian Chamber of Pharmacists, Upper Austria (APO)","place":["Linz, Austria"]}]},{"given":"Florian","family":"Ardelt","sequence":"additional","affiliation":[{"name":"Upper Austrian Society for General and Family Medicine (OBGAM)","place":["Linz, Austria"]}]},{"given":"Vicente J.","family":"Baixauli","sequence":"additional","affiliation":[{"name":"Spanish Society of Family and Community Pharmacies (SEFAC)","place":["Madrid, Spain"]}]},{"given":"Sergio","family":"Cinza-Sanjurjo","sequence":"additional","affiliation":[{"name":"Spanish Society of Primary Care Physicians (SEMERGEN)","place":["Madrid, Spain"]},{"name":"Milladoiro Health Center, Santiago de Compostela Health Area","place":["Madrid, Spain"]}]},{"given":"Kathrin","family":"Danninger","sequence":"additional","affiliation":[{"name":"Cardiology Department, Klinikum Wels-Grieskirchen","place":["Wels, Austria"]}]},{"given":"Mar\u00eda S.","family":"Fern\u00e1ndez-Alfonso","sequence":"additional","affiliation":[{"name":"Instituto Pluridisciplinar y Facultad de Farmacia UCM, Madrid, Spain","place":["Madrid, Spain"]},{"name":"IdISSC","place":["Madrid, Spain"]}]},{"given":"Luis","family":"Garc\u00eda-Ortiz","sequence":"additional","affiliation":[{"name":"Unidad de investigaci\u00f3n de Atenci\u00f3n Primaria de Salamanca (APISAL), Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL)","place":["Salamanca, Spain"]}]},{"given":"Viktoria","family":"Gastens","sequence":"additional","affiliation":[{"name":"La Source, School of Nursing Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland","place":["Lausanne, Switzerland"]}]},{"given":"Ana-Karen","family":"Guzm\u00e1n-Aguayo","sequence":"additional","affiliation":[{"name":"IdISSC","place":["Madrid, Spain"]}]},{"given":"Bernhard","family":"Hametner","sequence":"additional","affiliation":[{"name":"AIT Austrian Institute of Technology, Center for Health & Bioresources, Medical Signal Analysis","place":["Vienna, Austria"]}]},{"given":"Antonia M.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Spanish Society of Family and Community Pharmacies (SEFAC)","place":["Madrid, Spain"]}]},{"given":"Valeria","family":"Kopytina","sequence":"additional","affiliation":[{"name":"Spanish Society of Primary Care Physicians (SEMERGEN)","place":["Madrid, Spain"]}]},{"given":"Cristina","family":"Lugones-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Instituto Pluridisciplinar y Facultad de Farmacia UCM, Madrid, Spain","place":["Madrid, Spain"]}]},{"given":"Christopher C.","family":"Mayer","sequence":"additional","affiliation":[{"name":"Unidad de investigaci\u00f3n de Atenci\u00f3n Primaria de Salamanca (APISAL), Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL)","place":["Salamanca, Spain"]}]},{"given":"Zuri","family":"Montalar","sequence":"additional","affiliation":[{"name":"Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO)","place":["Valencia, Spain"]}]},{"given":"Telmo","family":"Pereira","sequence":"additional","affiliation":[{"name":"H&TRC - Health & Technology Research Center, Coimbra Health School, Polytechnic University of Coimbra","place":["Coimbra, Portugal"]}]},{"given":"Val\u00e9rie","family":"Santschi","sequence":"additional","affiliation":[{"name":"La Source, School of Nursing Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland","place":["Lausanne, Switzerland"]}]},{"given":"Wolfgang","family":"Schimetta","sequence":"additional","affiliation":[{"name":"Department of Applied Systems Research and Statistics, Johannes Kepler University","place":["Linz, Austria"]}]},{"given":"Thomas","family":"Weber","sequence":"additional","affiliation":[{"name":"Milladoiro Health Center, Santiago de Compostela Health Area","place":["Madrid, Spain"]}]},{"name":"TOGETHER-Project Research Group","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"ref1","year":""},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"D17","DOI":"10.1093\/eurheartj\/suz053","article-title":"May measurement month 2017: an analysis of blood pressure screening results in A-Europe","volume":"21","author":"Perl","year":"","journal-title":"Eur Heart J Suppl"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"H119","DOI":"10.1093\/eurheartj\/suaa044","article-title":"May measurement month 2018: an analysis of blood pressure screening results from Spain","volume":"22","author":"Rodilla","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/HJH.0000000000000162","article-title":"Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study","volume":"32","author":"Polonia","year":"2014","journal-title":"J Hypertens"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.cir.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe SCORE2 working group and ESC cardiovascular risk collaboration","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/2047487315588390","article-title":"Cardiovascular risk estimation in older persons: SCORE O.P","volume":"23","author":"Cooney","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"ref9","first-page":"883","article-title":"Risk prediction is improved by adding markers of subclinical organ damage to SCORE","volume-title":"Eur Heart J","author":"Sehestedt","year":"2010"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.medcli.2019.01.033","article-title":"Reclassification by applying the Framingham equation 30 years to subjects with intermediate cardiovascular risk. MARK study","volume":"153","author":"Gomez-Sanchez","year":"2019","journal-title":"Med Clin"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.medcli.2023.06.002","article-title":"Value of estimating pulse wave velocity compared to SCORE in cardiovascular risk stratification in community pharmacies","volume":"161","author":"Rodilla","year":"2023","journal-title":"Med Clin"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European renal association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehq165","article-title":"Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: \u2018establishing normal and reference values\u2019","volume":"31","year":"2010","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/MBP.0b013e3283614168","article-title":"Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements","volume":"18","author":"Hametner","year":"2013","journal-title":"Blood Press Monit"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1097\/HJH.0000000000001019","article-title":"Oscillometric analysis compared with cardiac magnetic resonance for the assessment of aortic pulse wave velocity in patients with myocardial infarction","volume":"34","author":"Feistritzer","year":"2016","journal-title":"J Hypertens"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/HJH.0b013e3282f314f7","article-title":"A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods","volume":"26","author":"Baulmann","year":"2008","journal-title":"J Hypertens"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/HJH.0000000000000518","article-title":"Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage","volume":"33","author":"Weber","year":"2015","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2261-12-48","article-title":"Assessment of central haemomodynamics from a brachial cuff in a community setting","volume":"12","author":"Nunan","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1097\/hjh.0000000000002178","article-title":"Cross-sectional analysis of pulsatile hemodynamics across the adult life span: reference values, healthy and early vascular aging: the Heinz Nixdorf recall and the multigeneration study","volume":"37","author":"Weber","year":"2019","journal-title":"J Hypertens"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41371-019-0222-y","article-title":"High prevalence of hypertension and early vascular aging: a screening program in pharmacies in Upper Austria","volume":"34","author":"Danninger","year":"2020","journal-title":"J Hum Hypertens"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.medcli.2017.04.037","article-title":"Arterial stiffness in normotensive and hypertensive subjects: frequency in community pharmacies","volume":"149","author":"Rodilla","year":"2017","journal-title":"Med Clin"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/jch.13554","article-title":"Measurement of arterial stiffness and vascular aging in community pharmacies \u2013 the ASINPHAR@2action project","volume":"21","author":"Pereira","year":"2019","journal-title":"J Clin Hypertens"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/HJH.0b013e32834aa769","article-title":"Effects of a multifaceted educational program on blood pressure and cardiovascular risk in hypertensive patients: the an project","volume":"29","author":"Perl","year":"2011","journal-title":"J Hypertens"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/2047487313518479","article-title":"Effectiveness of the heart age tool for improving modifiable cardiovascular risk factors in a southern European population: a randomized trial","volume":"22","author":"Lopez-Gonzalez","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/eurheartj\/ehae002","article-title":"Cardiovascular disease risk communication and prevention: a meta-analysis","volume":"45","author":"Bakhit","year":"2024","journal-title":"Eur Heart J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s11096-019-00856-w","article-title":"Impact of pharmacist's intervention on reducing cardiovascular risk in obese patients","volume":"41","author":"Huete","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.jacc.2016.03.528","article-title":"The effectiveness of pharmacist interventions on cardiovascular risk: the Multicenter randomized controlled RxEACH trial","volume":"67","author":"Tsuyuki","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e000687","DOI":"10.1136\/openhrt-2017-000687","article-title":"Effectiveness of pharmacist's intervention in the management of cardiovascular diseases","volume":"5","author":"Omboni","year":"2018","journal-title":"Open Heart"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e000718","DOI":"10.1161\/JAHA.113.000718","article-title":"Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials","volume":"3","author":"Santschi","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1001\/archinternmed.2011.399","article-title":"Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials","volume":"171","author":"Santschi","year":"2011","journal-title":"Arch Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jval.2019.05.012","article-title":"A cost analysis and cost-utility analysis of a community pharmacist-led intervention on reducing cardiovascular risk: the Alberta vascular risk reduction community pharmacy project (RxEACH)","volume":"22","author":"Tam-Tham","year":"2019","journal-title":"Value Health"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12875-024-02326-3","article-title":"Involving community pharmacists in interprofessional collaboration in primary care: a systematic review","volume":"25","author":"Angibaud","year":"2024","journal-title":"BMC Prim Care"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1161\/CIR.0000000000000597","article-title":"ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"138","author":"Whelton","year":"2017","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.hipert.2011.09.001","article-title":"Action guide for community pharmacist in patients with hypertension and cardiovascular risk. Consensus document (condensed version)","volume":"28","author":"Sabater-Hern\u00e1ndez","year":"2011","journal-title":"Hipertens Riesgo Vasc"},{"key":"ref35","volume-title":"Gu\u00eda para el abordaje de la hipertensi\u00f3n por el farmac\u00e9utico comunitario en el \u00e1mbito de la atenci\u00f3n primaria: documento de consenso multidisciplinar","author":"Pen\u00edn","year":"2022"},{"key":"ref36","year":""},{"key":"ref37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1331\/154434506778073592","article-title":"Utility of a questionnaire to measure physician-pharmacist collaborative relationships","volume":"46","author":"Zillich","year":"2006","journal-title":"J Am Pharm Assoc"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/ajh\/hpv186","article-title":"Randomized evaluation of the effectiveness of a structured educational program for patients with essential hypertension","volume":"29","author":"Perl","year":"2016","journal-title":"Am J Hypertens"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"760662","DOI":"10.3389\/fcvm.2021.760662","article-title":"Team-based Care for Improving Hypertension Management: a pragmatic randomized controlled trial","volume":"8","author":"Santschi","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref40","year":""},{"key":"ref41","volume-title":"Chapter 54 - e. network for research in vascular aging","author":"Mayer","year":"2024"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2991\/artres.k.200328.001","article-title":"Addressing the unmet needs of measuring vascular ageing in clinical practice\u2014European COoperation in science and technology action VascAgeNet","volume":"26","author":"Climie","year":"2020","journal-title":"Artery Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/eurjpc\/zwad028","article-title":"Vascular ageing: moving from bench towards bedside","volume":"30","author":"Climie","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1524-4733.2005.03093.x","article-title":"Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective","volume":"8","author":"Zillich","year":"2005","journal-title":"Value Health"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/ibd\/izaa056","article-title":"Utility of the MARS-5 in assessing medication adherence in IBD","volume":"27","author":"Stone","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref46","volume-title":"gMCP: Graph based multiple test procedures","author":"Kornelius","year":"2023"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/bimj.201000239","article-title":"Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes or parametric tests","volume":"53","author":"Bretz","year":"2011","journal-title":"Biom J"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e010396","DOI":"10.1161\/CIRCOUTCOMES.123.010396","article-title":"Role of health care professionals in the success of blood pressure control interventions in patients with hypertension: a meta-analysis","volume":"17","author":"Mills","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1477729","DOI":"10.3389\/fcvm.2025.1477729","article-title":"Pharmacists delivering hypertension care services: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Gastens","year":"2025","journal-title":"Front Cardiovasc Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1723100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:41:43Z","timestamp":1768372903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1723100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":49,"alternative-id":["10.3389\/fpubh.2025.1723100"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1723100","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1723100"}}